540359 — Parmax Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Parmax Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st
Period Length:	—	—
Source:	ARS	ARS
Standards:	IAS	IAS
Status:	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.07	0.51
Net Total Accounts Receivable
Net Total Receivables	28.2	33.2
Total Inventory
Total Other Current Assets
Total Current Assets	75.3	57.7
Net Property, Plant And Equipment	95	93.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	176	153
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	71.4	92.1
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	118	153
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	58.6	0.709
Total Liabilities & Shareholders' Equity	176	153
Total Common Shares Outstanding